1,081
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Immune therapy, a double-edged sword for oncolytic viruses

&
Pages 1111-1113 | Received 13 Jun 2019, Accepted 29 Jul 2019, Published online: 06 Aug 2019
 

Declaration of interest

The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial relationships or otherwise to disclose.

Additional information

Funding

This authors are supported by funding from the National Institute of Health [P01CA163205, R01NS064607 and R01 CA150153].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.